This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds targeting neurological disorders, including antidepressants and antipsychotics. Its structure, featuring a morpholine ring and a fluorophenyl group, makes it valuable for modulating receptor activity in the central nervous system. Additionally, it is explored in medicinal chemistry for its potential in designing novel drugs with improved efficacy and selectivity. Researchers also investigate its role in optimizing pharmacokinetic properties of drug candidates.